Pharmacodynamic effects of the PARP inhibitor talazoparib (MDV3800, BMN 673) in patients with BRCA-mutated advanced solid tumors
Article in Cancer Chemotherapy and Pharmacology (November 2023)
The most recent citing publications are shown below. View all 43 publications that cite this research output on Dimensions.
Article in Cancer Chemotherapy and Pharmacology (November 2023)
Article in BMC Cancer (April 2023)
Article in Frontiers in Pharmacology (March 2023)